|  | CKD | Controls |  | CKD | Controls |
---|---|---|---|---|---|---|
SAX:Base | Epi S | -13.3 +/- 2.3†| -15.9 +/- 2.9 | Epi SR | -1.1 +/- 0.4†| -1.4 +/- 0.5 |
 | MW S | -13.0 +/- 2.3†| -15.6 +/- 2.9 | MW SR | -0.7 +/- 0.4†| -1.4 v 0.5 |
 | Endo S | -18.1 +/- 3.2†| -21.0 +/- 4.4 | Endo SR | -0.5 +/- 0.2†| -1.1 +/- 0.2 |
SAX:Mid | Epi S | -13.3 +/- 2.0 | -13.1 +/- 2.0 | Epi SR | -1.6 +/- 0.5 | 1.4 +/- 0.6 |
 | MW S | -19.0 +/- 2.1 | -18.0 +/- 2.1 | MW SR | -1.1 +/- 0.4 | -1.2 +/- 0.4 |
 | MW S | -25.2 +/- 2.5 | -24.0 +/- 2.1 | Endo SR | -1.0 +/- 1.1 | -1.2 +/- 0.2 |
SAX:Apex | Epi S | -13.8 +/- 1.7 | -14.4 +/- 2.3 | Epi SR | -1.6 +/- 0.7 | -1.1 +/- 0.7 |
 | MW S | -19.9 +/- 1.9 | -19.6 +/- 1.7 | MW SR | -1.0 +/- 0.4 | -1.0 +/- 0.4 |
 | Endo S | -28.2 +/- 2.8 | -27.7 +/- 2.9 | Endo SR | -1.3 +/- 0.3 | -1.4 +/- 0.5 |
LAX | Epi S | -12.7 +/- 1.7†| -14.7 +/- 2.9 | Epi SR | 0.7 +/- 0.1 | -0.8 +/- 0.1 |
 | MW S | -14.1 +/- 1.7†| -16.1 +/- 2.1 | MW SR | -0.8 +/- 0.2 | -0.97 +/- 0.1†|
 | Endo S | -15.4 +/- 2.8†| -17.8 +/- 2.0 | Endo SR | -0.9 +/- 0.1 | -1.09 +/- 0.1†|
LV Mass (g/m2) | 57 +/- 22 | 59 +/- 11 | Â | Â | Â | |
LVEF (%) | 74 +/- 7 | 75 +/- 5 | Â | Â | Â |